Annual Interest Expense
$9.89 M
-$2.46 M-19.90%
December 31, 2023
Summary
- As of February 20, 2025, AVDL annual interest expense is $9.89 million, with the most recent change of -$2.46 million (-19.90%) on December 31, 2023.
- During the last 3 years, AVDL annual interest expense has fallen by -$3.11 million (-23.92%).
- AVDL annual interest expense is now -23.92% below its all-time high of $12.99 million, reached on December 31, 2020.
Performance
AVDL Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Interest Expense
$2.82 M
+$104.00 K+3.83%
September 30, 2024
Summary
- As of February 20, 2025, AVDL quarterly interest expense is $2.82 million, with the most recent change of +$104.00 thousand (+3.83%) on September 30, 2024.
- Over the past year, AVDL quarterly interest expense has increased by +$466.00 thousand (+19.80%).
- AVDL quarterly interest expense is now -50.60% below its all-time high of $5.71 million, reached on March 31, 2014.
Performance
AVDL Quarterly Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Interest Expense
$10.48 M
+$842.00 K+8.73%
September 30, 2024
Summary
- As of February 20, 2025, AVDL TTM interest expense is $10.48 million, with the most recent change of +$842.00 thousand (+8.73%) on September 30, 2024.
- Over the past year, AVDL TTM interest expense has increased by +$596.00 thousand (+6.03%).
- AVDL TTM interest expense is now -22.84% below its all-time high of $13.58 million, reached on March 31, 2023.
Performance
AVDL TTM Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Interest Expense Formula
Interest Expense = Carrying Value of Debt X Effective Interest Rate
AVDL Interest Expense Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -19.9% | +19.8% | +6.0% |
| 3 y3 years | -23.9% | +22.9% | -15.3% |
| 5 y5 years | -6.9% | +22.9% | -15.3% |
AVDL Interest Expense Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -19.9% | at low | -32.1% | +42.6% | -22.8% | +13.7% |
| 5 y | 5-year | -23.9% | at low | -32.1% | +46.2% | -22.8% | +15.2% |
| alltime | all time | -23.9% | -100.0% | -50.6% | +222.5% | -22.8% | +1981.9% |
Avadel Pharmaceuticals Interest Expense History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $2.82 M(+3.8%) | $10.48 M(+8.7%) |
| Jun 2024 | - | $2.72 M(+4.8%) | $9.64 M(+4.6%) |
| Mar 2024 | - | $2.59 M(+10.1%) | $9.22 M(-6.7%) |
| Dec 2023 | $9.89 M(-19.9%) | $2.35 M(+19.0%) | $9.89 M(-8.4%) |
| Sep 2023 | - | $1.98 M(-13.8%) | $10.79 M(-12.8%) |
| Jun 2023 | - | $2.29 M(-29.6%) | $12.37 M(-8.9%) |
| Mar 2023 | - | $3.26 M(+0.1%) | $13.58 M(+10.1%) |
| Dec 2022 | $12.34 M(+24.1%) | $3.25 M(-8.7%) | $12.34 M(-6.8%) |
| Sep 2022 | - | $3.56 M(+1.7%) | $13.24 M(+14.1%) |
| Jun 2022 | - | $3.51 M(+73.8%) | $11.61 M(+15.7%) |
| Mar 2022 | - | $2.02 M(-51.4%) | $10.03 M(+0.9%) |
| Dec 2021 | $9.94 M(-23.5%) | $4.15 M(+115.3%) | $9.94 M(+9.3%) |
| Sep 2021 | - | $1.93 M(-0.1%) | $9.10 M(-12.8%) |
| Jun 2021 | - | $1.93 M(+0.1%) | $10.43 M(-11.1%) |
| Mar 2021 | - | $1.93 M(-41.7%) | $11.73 M(-9.7%) |
| Dec 2020 | $12.99 M(+4.1%) | $3.31 M(+1.5%) | $12.99 M(+0.9%) |
| Sep 2020 | - | $3.26 M(+0.7%) | $12.88 M(+1.1%) |
| Jun 2020 | - | $3.24 M(+1.5%) | $12.74 M(+1.0%) |
| Mar 2020 | - | $3.19 M(0.0%) | $12.61 M(+1.0%) |
| Dec 2019 | $12.48 M(+17.5%) | $3.19 M(+2.1%) | $12.48 M(+1.2%) |
| Sep 2019 | - | $3.13 M(+0.6%) | $12.34 M(+1.0%) |
| Jun 2019 | - | $3.11 M(+1.4%) | $12.21 M(+1.0%) |
| Mar 2019 | - | $3.06 M(+0.6%) | $12.09 M(+13.8%) |
| Dec 2018 | $10.62 M | $3.04 M(+1.5%) | $10.62 M(+35.5%) |
| Sep 2018 | - | $3.00 M(+0.7%) | $7.84 M(+53.6%) |
| Jun 2018 | - | $2.98 M(+86.6%) | $5.10 M(+113.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2018 | - | $1.60 M(+507.2%) | $2.39 M(+126.8%) |
| Dec 2017 | $1.05 M(+9.2%) | $263.00 K(0.0%) | $1.05 M(+0.2%) |
| Sep 2017 | - | $263.00 K(0.0%) | $1.05 M(-0.1%) |
| Jun 2017 | - | $263.00 K(0.0%) | $1.05 M(0.0%) |
| Mar 2017 | - | $263.00 K(+0.8%) | $1.05 M(+9.1%) |
| Dec 2016 | $963.00 K(>+9900.0%) | $261.00 K(-1.1%) | $963.00 K(+37.2%) |
| Sep 2016 | - | $264.00 K(+0.4%) | $702.00 K(+60.3%) |
| Jun 2016 | - | $263.00 K(+50.3%) | $438.00 K(+150.3%) |
| Mar 2016 | - | $175.00 K(>+9900.0%) | $175.00 K(-131.4%) |
| Dec 2015 | $0.00(-100.0%) | - | - |
| Jun 2015 | - | $0.00(-100.0%) | -$557.00 K(-206.7%) |
| Mar 2015 | - | $259.00 K(-111.3%) | $522.00 K(-91.3%) |
| Dec 2014 | $5.75 M(+25.2%) | -$2.30 M(-254.9%) | $5.97 M(-34.2%) |
| Sep 2014 | - | $1.49 M(+37.7%) | $9.08 M(+9.5%) |
| Jun 2014 | - | $1.08 M(-81.1%) | $8.29 M(-16.0%) |
| Mar 2014 | - | $5.71 M(+607.3%) | $9.87 M(+115.0%) |
| Dec 2013 | $4.59 M(+3791.5%) | $807.00 K(+15.1%) | $4.59 M(+17.7%) |
| Sep 2013 | - | $701.00 K(-73.6%) | $3.90 M(+21.9%) |
| Jun 2013 | - | $2.65 M(+518.9%) | $3.20 M(+485.4%) |
| Mar 2013 | - | $429.00 K(+263.6%) | $547.00 K(+363.6%) |
| Dec 2012 | $118.00 K(+61.6%) | $118.00 K(>+9900.0%) | $118.00 K(>+9900.0%) |
| Sep 2012 | - | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2012 | - | $0.00 | $0.00 |
| Dec 2011 | $73.00 K(+204.2%) | - | - |
| Dec 2010 | $24.00 K(-76.0%) | - | - |
| Dec 2009 | $100.00 K(+455.6%) | - | - |
| Dec 2008 | $18.00 K | - | - |
FAQ
- What is Avadel Pharmaceuticals annual interest expense?
- What is the all time high annual interest expense for Avadel Pharmaceuticals?
- What is Avadel Pharmaceuticals annual interest expense year-on-year change?
- What is Avadel Pharmaceuticals quarterly interest expense?
- What is the all time high quarterly interest expense for Avadel Pharmaceuticals?
- What is Avadel Pharmaceuticals quarterly interest expense year-on-year change?
- What is Avadel Pharmaceuticals TTM interest expense?
- What is the all time high TTM interest expense for Avadel Pharmaceuticals?
- What is Avadel Pharmaceuticals TTM interest expense year-on-year change?
What is Avadel Pharmaceuticals annual interest expense?
The current annual interest expense of AVDL is $9.89 M
What is the all time high annual interest expense for Avadel Pharmaceuticals?
Avadel Pharmaceuticals all-time high annual interest expense is $12.99 M
What is Avadel Pharmaceuticals annual interest expense year-on-year change?
Over the past year, AVDL annual interest expense has changed by -$2.46 M (-19.90%)
What is Avadel Pharmaceuticals quarterly interest expense?
The current quarterly interest expense of AVDL is $2.82 M
What is the all time high quarterly interest expense for Avadel Pharmaceuticals?
Avadel Pharmaceuticals all-time high quarterly interest expense is $5.71 M
What is Avadel Pharmaceuticals quarterly interest expense year-on-year change?
Over the past year, AVDL quarterly interest expense has changed by +$466.00 K (+19.80%)
What is Avadel Pharmaceuticals TTM interest expense?
The current TTM interest expense of AVDL is $10.48 M
What is the all time high TTM interest expense for Avadel Pharmaceuticals?
Avadel Pharmaceuticals all-time high TTM interest expense is $13.58 M
What is Avadel Pharmaceuticals TTM interest expense year-on-year change?
Over the past year, AVDL TTM interest expense has changed by +$596.00 K (+6.03%)